Researchers have introduced SymptomAI, an investigational conversational AI agent for conducting real-world patient interviews and symptom assessments. The work is described as an exploratory research effort and highlights both the potential of AI-based symptom assessment and the limits of comparing it with clinician assessments.
The source says a population deployment evaluation found accuracy in symptom assessment through remote patient interviews, but notes that differential diagnosis is an ambiguous task and that reported diagnoses may change over time. It also says symptom assessment is a snapshot in time, and the team could not control for the frequency and timing of symptom reporting during the deployment.
That means some participants may have reported symptoms before more representative indicators developed, while others may have reported obvious indicators from an informed context after years of experience with chronic illness. The source says future work may focus on specific illnesses at specific points during symptom development such as early-onset metabolic syndrome or symptoms discussed at the start of respiratory infections.
The evaluation also had limits in how clinicians reviewed the material. Clinicians reviewed static chat transcripts and were not given agency to ask their own follow-up questions. The source says clinicians may have sourced different information had they directed the symptom interview.
The research points to another constraint: conversational AI systems may source clinical data with a clinician-level of detail and accuracy, but they may miss alternative signals such as body language, visual assessment, medical records, or, in primary care, existing rapport with the patient.
The source says all diagnoses, labels, and disease associations generated during the study are AI-derived for research analysis only and do not constitute confirmed clinical diagnoses or official medical assessments. It adds that SymptomAI diagnoses can enable analysis of population-scale signals like wearable biosignals for identifying associations in physiological signals with reported illness.
Source: research.google.
Companies can share verified announcements through Newz9’s international press release submission page.
